Effectiveness and Tolerability of Ipilimumab: Experiences From 198 Patients Included in a Named-Patient Program in Various Daily-Practice Settings and Multiple Institutions

Eigentler, Thomas K.; Schlaak, Max; Hassel, Jessica C.; Loquai, Carmen; Stoffels, Ingo; Gutzmer, Ralf'; Paetzold, Sylvie; Mohr, Peter; Keller, Ulrich; Starz, Hans; Ulrich, Jens; Tsianakas, Athanasios; Kaehler, Katharina; Hauschild, Axel; Janssen, Eva; Schuler-Thurner, Beatrice; Weide, Benjamin; Garbe, Claus

dc.contributor.author	Garbe, Claus
dc.contributor.author	Eigentler, Thomas
dc.contributor.author	Weide, Benjamin Matthias
dc.date.accessioned	2014-12-09T13:52:41Z
dc.date.available	2014-12-09T13:52:41Z
dc.date.issued	2014
dc.identifier.issn	1524-9557
dc.identifier.uri	http://hdl.handle.net/10900/58375
dc.language.iso	en	en
dc.publisher	Lippincott Williams & Wilkins	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Effectiveness and Tolerability of Ipilimumab: Experiences From 198 Patients Included in a Named-Patient Program in Various Daily-Practice Settings and Multiple Institutions	de_DE
dc.type	Article	de_DE
utue.quellen.id	20141022002833_00180	de_DE
utue.publikation.seiten	374-381	de_DE
utue.personen.roh	Eigentler, Thomas K.
utue.personen.roh	Schlaak, Max
utue.personen.roh	Hassel, Jessica C.
utue.personen.roh	Loquai, Carmen
utue.personen.roh	Stoffels, Ingo
utue.personen.roh	Gutzmer, Ralf'
utue.personen.roh	Paetzold, Sylvie
utue.personen.roh	Mohr, Peter
utue.personen.roh	Keller, Ulrich
utue.personen.roh	Starz, Hans
utue.personen.roh	Ulrich, Jens
utue.personen.roh	Tsianakas, Athanasios
utue.personen.roh	Kaehler, Katharina
utue.personen.roh	Hauschild, Axel
utue.personen.roh	Janssen, Eva
utue.personen.roh	Schuler-Thurner, Beatrice
utue.personen.roh	Weide, Benjamin
utue.personen.roh	Garbe, Claus
dcterms.isPartOf.ZSTitelID	Journal of Immunotherapy	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	37	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE